SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Eris Lifesciences informs about conference call

21 Jan 2022 Evaluate
Lifesciences has informed that the Company will hold a conference call for analysts and investors on Friday, 28th January, 2022, after declaration of the standalone and consolidated unaudited financial results of the Company for the quarter and nine months ended 31st December, 2021. The details of the said call are attached herewith and also available on Company's website.

The above information is a part of company’s filings submitted to BSE.

Eris Lifesciences Share Price

1440.45 -28.70 (-1.95%)
22-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1942.95
Dr. Reddys Labs. 1183.00
Cipla 1415.10
Lupin 2405.80
Zydus Lifesciences 1129.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: